诚意药业：累计回购约962万股

Core Viewpoint - Chengyi Pharmaceutical announced a share buyback plan, indicating confidence in its stock value and future prospects [2] Group 1: Share Buyback Details - As of July 31, 2025, the company has repurchased approximately 9.62 million shares, accounting for 2.94% of its total share capital [2] - The highest transaction price during the buyback was 8.36 CNY per share, while the lowest was 7.25 CNY per share [2] - The total amount spent on the buyback was approximately 76.4 million CNY [2] Group 2: Revenue Composition - For the year 2024, the revenue composition of Chengyi Pharmaceutical is as follows: 99.71% from the pharmaceutical manufacturing sector and 0.29% from other businesses [2]